Lv1
60 积分 2025-03-21 加入
Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol
1个月前
已关闭
Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories
1个月前
已关闭
Bioavailability of enteral tramadol formulations. 1st communication: capsules
1个月前
已关闭
Tramadol Induced QTc-Interval Prolongation: Prevalence, Clinical Factors and Correlation to Plasma Concentrations
1个月前
已完结
Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of SHR4640, a Selective Urate Transporter 1 Inhibitor, in Healthy Chinese Male Volunteers
2个月前
已完结
Role of CYP2D6 polymorphisms in tramadol metabolism in a context of co-medications and overweight
2个月前
已完结
Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention
2个月前
已完结
Efficacy and safety of dotinurad versus febuxostat for the treatment of gout: a randomised, multicentre, double‐blind, phase 3 trial in China
2个月前
已完结
The calcipotriol dose–irritation relationship: 48 hour occlusive testing in healthy volunteers using Finn Chambers ®
2个月前
已完结
Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses
4个月前
已完结
皖公网安备34019202002308
